TCT 2022 | BYPASS CTCA

Studies have shown that the use of computed tomography cardiac angiography (CTCA) prior invasive coronary angiography (ICA) in patients with prior cardiac artery bypass graft (CABG) might reduce procedural time and post procedure kidney injury. 1 out of 5 patients with ischemic cardiomyopathy and prior CABG need to be assessed with ICA within 3 years after procedure. 

TCT 2022

The aim of this single center, prospective, randomized study called BYPASS CTCA was to assess whether the use of CTCA can reduce procedural time, improve patient satisfaction and prevent procedural complication in CABG patients assessed by ICA. 

It included 688 patients. 344 were randomized to CTCA + ICA and 344 to ICA alone. Mean age was 70 and most patients were men.  

Primary end point was procedure duration, incidence of contrast induced nephropathy and patient satisfaction assessed by a score. Secondary end point included procedural complications and major cardiovascular events (MACE) at 12 months. 

As regards primary end point, the use of CTCA saw an improvement associated to the invasive study. Procedure duration was 17.38 minutes with CTCA vs 39.5 without it, with 66% relative risk reduction (p<0.001), and patient satisfaction improved 40% with the use of CTCA (p<0.001), while contrast induced nephropathy incidence was 27.9% without CTCA vs 3.4% with CTCA (92% relative risk reduction, p<0.0001). 

Read also: TCT 2022 | PROTECTED TAVR.

As regards secondary end point, the use of CTCA + ICA resulted in lower procedural complications (2.33% vs 10.82%, p<0.001) and MACE rates at 12 months (16.28 vs 29.36%, p< 0.002).

Conclusion

In patients with prior CABG undergoing invasive coronary angiogram, the use of CTCA should be considered, seeing as is shortens procedural time, improves patient satisfaction and reduces contrast induced nephropathy. In addition, the use of CTCA reduces complications rate and MACE rate at 12 months. 

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: A Randomized Controlled Trial Assessing The Value Of Computed Tomography Cardiac Angiography (CTCA) In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous Bypass Operation (CABG). Results from the BYPASS CTCA Trial.

Reference: Daniel A. Jones et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...